Takuo Yamai

9PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsMedical biotechnology diagnostics (incl. biosensors)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 14, 2026
Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75 Years and Older With Unresectable Pancreatic Cancer.

|Jan 01, 2025
Comparison of sedation with pentazocine or pethidine hydrochloride for endoscopic ultrasonography in outpatients: A single-center retrospective study.

Makiko Urabe, Kenji Ikezawa, Yusuke Seiki

|Nov 18, 2024
Initial adjustments in the dosage and rest period of gemcitabine plus cisplatin therapy for patients with incurable biliary tract cancer based on baseline estimated glomerular filtration rate (eGFR) values may be crucial for treatment outcomes and the preservation of renal function.

Takanori Masumoto, Takuo Yamai, Kazuki Nakamura

|May 06, 2024
Oil blotting paper for formalin fixation increases endoscopic ultrasound-guided tissue acquisition-collected sample volumes on glass slides.

Takuo Yamai, Kenji Ikezawa, Yusuke Seiki

|Feb 21, 2024
Comparison of percutaneous ablation and hepatectomy for liver metastasis: A single center retrospective study.

Seiichi Tawara, Tetsuro Miyazaki, Ryosuke Kiyota

|Apr 20, 2023
A case of multiple myeloma with pancreatic involvement diagnosed via endoscopic ultrasound-guided fine needle aspiration.

Erika Hiraga, Takuo Yamai, Kenji Ikezawa

Pageof 2

Frequent Collaborators

6 joint publications

Kenji Ikezawa

5 joint publications

Ryoji Takada

3 joint publications

Tasuku Nakabori

2 joint publications

Makiko Urabe